Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone affects brain behavior in complex and varied ways.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Low testosterone may increase COVID-19 severity in men.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Older men with lower levels of available testosterone are more likely to be frail.

New treatments for male hypogonadism are effective and should be personalized.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Finasteride effectively treats baldness but may cause sexual side effects.

Some common medications can harm male fertility, but many effects can be reversed.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Some medications can cause acne, and stopping these drugs is the main treatment.